Cannizzo Joseph P, Chai Audrey L, Do Christopher T, Wilson Melissa L, Liebler Janice M, Huerta Luis E
Department of Emergency Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Crit Care Explor. 2023 Jul 14;5(7):e0947. doi: 10.1097/CCE.0000000000000947. eCollection 2023 Jul.
We sought to identify the primary causes of death of adult patients admitted to the medical ICU with symptomatic COVID-19 who ultimately suffered in-hospital mortality over the span of three major waves of COVID-19: Wild-type, alpha/epsilon, and delta.
Retrospective single-center cohort study from March 2020 to December 2021.
One medical ICU in a 600-bed Tertiary Care Hospital in Los Angeles, CA.
Adult ( = 306) ICU patients admitted with symptomatic COVID-19 who suffered in-hospital mortality.
None.
Of the 306 patients with COVID-19 who died in the hospital, 86.3% were Hispanic/Latino. The leading cause of death was respiratory failure, occurring in 57.8% of patients. There was no significant change in the rate of pulmonary deaths across the three waves of COVID-19 in our study period. The mean time from symptom onset to admission was 6.5 days, with an average hospital length of stay of 18 days. This did not differ between pulmonary and other causes of death. Sepsis was the second most common cause of death at 23.9% with a significant decrease from the wild-type wave to the delta wave. Among patients with sepsis as the cause of death, 22% ( = 16) were associated with fungemia. There was no significant association between steroid administration and cause of death. Lastly, the alpha/epsilon wave from December 2020 to May 2021 had the highest mortality rate when compared with wild-type or delta waves.
We found the primary cause of death in ICU patients with COVID-19 was acute respiratory failure, without significant changes over the span of three waves of COVID-19. This finding contrasts with reported causes of death for patients with non-COVID-19 acute respiratory distress syndrome, in which respiratory failure is an uncommon cause of death. In addition, we identified a subset of patients (5%) who died primarily due to fungemia, providing an area for further investigation.
我们试图确定因有症状的新型冠状病毒肺炎(COVID-19)入住内科重症监护病房(ICU)且最终在院内死亡的成年患者的主要死因,研究涵盖了COVID-19的三波主要疫情:野生型、α/ε型和δ型。
2020年3月至2021年12月的回顾性单中心队列研究。
加利福尼亚州洛杉矶一家拥有600张床位的三级护理医院的一个内科ICU。
306名因有症状的COVID-19入住ICU且在院内死亡的成年患者。
无。
在306例死于医院的COVID-19患者中,86.3%为西班牙裔/拉丁裔。主要死因是呼吸衰竭,57.8%的患者出现该情况。在我们的研究期间,三波COVID-19疫情中肺部疾病导致的死亡率没有显著变化。从症状出现到入院的平均时间为6.5天,平均住院时间为18天。这在因肺部疾病和其他死因导致死亡的患者之间没有差异。脓毒症是第二常见的死因,占23.9%,从野生型疫情到δ型疫情有显著下降。在因脓毒症导致死亡的患者中,22%(n = 16)与真菌血症有关。使用类固醇与死因之间没有显著关联。最后,与野生型或δ型疫情相比,2020年12月至2021年5月的α/ε型疫情死亡率最高。
我们发现COVID-19的ICU患者的主要死因是急性呼吸衰竭,在三波COVID-19疫情期间没有显著变化。这一发现与非COVID-19急性呼吸窘迫综合征患者报告的死因形成对比,在后者中呼吸衰竭是不常见的死因。此外,我们确定了一部分主要因真菌血症死亡的患者(5%),这为进一步研究提供了一个领域。